Sun Pharmaceutical Industries net profit is projected to reach Rs 2,911 crore, a 22.5% increase from the previous year. Reach around ₹2,911 crore, up from ₹2,376 crore in the same quarter last fiscal year. Additionally, revenue is expected to grow approximately 9% to ₹13,299 crore compared to ₹12,192 crore last year.
Sun Pharmaceutical Industries is expected to report a double-digit growth in net profit for the July-September quarter due to favorable seasonality and strong specialty sales.